PBYI vs GILD: Which Stock is Better?
Side-by-side comparison of Puma Biotechnology Inc and Gilead Sciences Inc in 2026
PBYI
Puma Biotechnology Inc
$7.47
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | PBYI | GILD | Winner |
|---|---|---|---|
| Market Cap | $368.35M | $171.97B | GILD |
| P/E Ratio | 11.87 | 20.44 | PBYI |
| EPS (TTM) | $0.61 | $6.78 | GILD |
| Revenue Growth | 0.3% | 0.0% | PBYI |
| Gross Margin | 74.5% | 78.8% | GILD |
Analyze PBYI
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PBYI or GILD a better investment?
Comparing PBYI and GILD: Puma Biotechnology Inc has a market cap of $368.35M while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PBYI and GILD?
PBYI (Puma Biotechnology Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PBYI or GILD?
Based on P/E ratios, PBYI trades at a lower multiple (11.9x vs 20.4x).
Which is growing faster: PBYI or GILD?
PBYI has higher revenue growth at 0.3% vs 0.0% for GILD.
Which company is more profitable: PBYI or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 74.5% for PBYI.
Which is the larger company: PBYI or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $368.35M for PBYI.
Should I buy PBYI or GILD in 2026?
Both PBYI and GILD have investment merit. PBYI trades at $7.47 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PBYI and GILD stock?
Key differences: Market Cap ($368.35M vs $171.97B), P/E Ratio (11.9x vs 20.4x), Revenue Growth (0.3% vs 0.0%), Gross Margin (74.5% vs 78.8%).